Kazutomo Sawai | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Kazutomo Sawai | Health Professions | Best Researcher Award

President from Hanshin Medical Co-op Daisan Clinic, Japan

Dr. Kazutomo Sawai is a distinguished Japanese physician-researcher specializing in nephrology and Kampo (traditional Japanese) medicine. He has made outstanding contributions to the understanding of glomerular regeneration, diabetic nephropathy, and molecular markers of kidney disease. With over two decades of clinical and research experience, Dr. Sawai combines modern medical science with traditional therapeutic approaches to address complex renal pathologies. His professional journey encompasses high-level academic training, fellowships at prominent institutions, and leadership roles within clinical practice and education. Since 2010, he has served as President of Daisan Clinic in Amagasaki, Hyogo, Japan, where he also champions patient education and community healthcare. Dr. Sawai’s international presence is marked by presentations at global nephrology congresses, highlighting his pivotal research on Connexin43 and Cyr61 expression in diabetic nephropathy and glomerulonephritis. His clinical insights are further enriched through his integration of Kampo medicine, reflected in his successful management of chronic cases through traditional prescriptions. A fellow of multiple Japanese medical societies, he has received notable honors for his scientific achievements. Dr. Sawai remains a committed clinician, educator, and researcher, dedicated to translational nephrology, patient-centered care, and the advancement of integrative medicine practices.

Professional Profile

Education

Dr. Kazutomo Sawai pursued his foundational medical education at the esteemed Kyoto University School of Medicine, obtaining his M.D. in 1995. Demonstrating an early interest in renal pathophysiology, he continued his academic journey by earning a Ph.D. in Renal Physiology from Kyoto University Graduate School of Medicine in 2004. His doctoral work focused on glomerular disease mechanisms and the role of angiogenic and podocyte-specific factors in kidney regeneration. Dr. Sawai’s postgraduate training included a comprehensive residency in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital between 1995 and 1997. He later undertook specialized fellowships in nephrology and dialysis therapy from 1998 to 2001 at both Saiseikai Nakatsu and Kyoto University Hospitals. Expanding his scope beyond conventional medicine, Dr. Sawai completed dual fellowships in Kampo medicine between 2015 and 2018 at Midorinokaze Clinic and Rakuwakai Otowa Hospital. This diverse academic and clinical training underpins his multidisciplinary approach to kidney care, integrating Western biomedical science with traditional Japanese therapeutics. Dr. Sawai’s strong academic background has laid a robust foundation for his research contributions and clinical leadership, positioning him as a key figure in the evolution of nephrology and holistic patient care in Japan.

Professional Experience

Dr. Sawai has cultivated an illustrious professional career marked by significant academic, clinical, and administrative roles. His early medical career began with residencies in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital from 1995 to 1997. He then specialized in nephrology and dialysis therapy during fellowships at these institutions through 2001. Dr. Sawai’s academic appointments include a role as Project Researcher in Internal Medicine at Kyoto University in 2004 and a notable tenure as Chief Researcher at the National Cardiovascular Center Research Institute in Osaka from 2004 to 2010. In 2010, he assumed the presidency of Daisan Clinic in Amagasaki, where he continues to practice, lead, and mentor. His responsibilities extend to community health, serving as Medical Director and Adviser for local home care services, and contributing as a committee member overseeing free and low-cost medical programs. He has also taught at Saiseikai Nakatsu Nursing School and Hanshin Cooperative Association Community College. With an integrated focus on internal medicine, nephrology, dialysis, and Kampo medicine, Dr. Sawai’s professional journey reflects a commitment to advancing holistic healthcare, clinical education, and community outreach.

Research Interest

Dr. Sawai’s research interests span the molecular, cellular, and clinical dimensions of nephrology. His work is particularly focused on the pathophysiology of glomerular diseases, including diabetic nephropathy, anti-GBM nephritis, and glomerulonephritis. He has extensively investigated the roles of podocyte-specific genes, such as Cyr61 (CCN1) and Connexin43, in renal injury and regeneration. These studies have led to insights into the mechanisms of podocyte dysfunction and the potential use of angiogenic and regenerative factors in predicting or improving renal outcomes. A pioneer in integrating traditional medicine into modern nephrology, Dr. Sawai has also explored the therapeutic applications of Kampo prescriptions in managing chronic symptoms such as dementia, hypertension, and neuropathic pain. His case studies highlight the efficacy of herbal formulations in complex clinical scenarios that often resist conventional treatment. His broader interest encompasses translational nephrology, where laboratory discoveries can inform clinical practice. With a comprehensive understanding of both biomedical science and traditional Japanese healing systems, Dr. Sawai’s research bridges disciplines to deliver patient-centered, evidence-based, and integrative kidney care. His continuous presence at national and international conferences further demonstrates his commitment to advancing nephrology and promoting the fusion of traditional and modern medical systems.

Research Skills

Dr. Sawai brings a sophisticated portfolio of research skills to the field of nephrology and integrative medicine. Trained in both clinical and bench research environments, he has demonstrated strong capabilities in experimental nephrology, molecular biology, and pathophysiological analysis. His core competencies include immunohistochemistry, gene expression profiling, and biomarker discovery, particularly focusing on proteins like Cyr61 and Connexin43 in renal pathology. His collaborative research has leveraged rodent models of glomerulonephritis and diabetic nephropathy to explore regeneration pathways in the kidney. Dr. Sawai’s ability to translate these findings into clinical insights distinguishes his work in translational medicine. Additionally, his skills extend to clinical trial design, retrospective case analysis, and Kampo prescription efficacy assessment, making him a rare blend of experimental and clinical researcher. He is also an experienced academic presenter and has delivered over 30 presentations at regional, national, and international conferences. His capacity for multidisciplinary collaboration, particularly in combining conventional nephrology with traditional Japanese Kampo medicine, reflects advanced integrative research skills. Through his leadership at Daisan Clinic, he continues to apply these skills in real-world settings, facilitating a seamless interface between research innovation and patient care.

Awards and Honors

Throughout his career, Dr. Kazutomo Sawai has received multiple accolades in recognition of his academic and research excellence. Among the earliest distinctions was the Miyake Memorial Award from Kyoto University Graduate School of Medicine in 2003, acknowledging his contributions to internal medicine and clinical science. In 2004, he was the recipient of the Tsujisaka Memorial Scholarship, awarded for scholarly promise and research potential in the field of renal physiology. The Young Researcher’s Award conferred at the 42nd Annual Meeting of the Japanese Society of Molecular Medicine in 2005 further highlighted his innovative work on glomerular regeneration. He also earned a Travel Grant from the American Society of Nephrology, which enabled him to present his research at international platforms and expand cross-border academic exchange. These honors not only affirm his impactful scientific work but also emphasize his contributions to the global discourse on nephrology. Dr. Sawai’s recognition by both Japanese and international institutions reflects the high quality and significance of his research. His continued academic output and interdisciplinary approach ensure that he remains at the forefront of innovation in renal medicine and integrative therapies.

Conclusion

Dr. Kazutomo Sawai stands out as a clinician-researcher of exceptional caliber, whose multifaceted career bridges the realms of nephrology, internal medicine, and Kampo therapeutics. His academic foundation at Kyoto University, combined with specialized fellowships in nephrology and traditional medicine, has shaped a unique professional identity that is both modern and rooted in tradition. As President of Daisan Clinic, he has made significant contributions to clinical nephrology while also enhancing community health services and medical education. Dr. Sawai’s research has had a profound impact on the understanding of podocyte biology, glomerular regeneration, and diabetic nephropathy, with practical applications for improving patient outcomes. His pioneering integration of Kampo medicine into nephrology offers novel approaches to managing chronic, treatment-resistant conditions. Despite a lack of editorial roles, his active participation in national and international scientific forums and multiple honors confirm his standing in the field. Dr. Sawai exemplifies dedication to science, education, and compassionate patient care, making him an ideal candidate for prestigious recognition such as the Best Researcher Award. His work continues to inspire the next generation of healthcare professionals and researchers in Japan and beyond.

Publications Top Notes

1. Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function

  • Year: 1997

  • Authors: Tanaka A, Nishida R, Sawai K, Nagae T, Shinkai S, Ishikawa M, Maeda K, Murata M, Seta K, Okuda J, Yoshida T, Sugawara A, Kuwahara T

  • Journal: Nihon Jinzo Gakkai Shi

2. Human parvovirus B19 infection resembling systemic lupus erythematosus

  • Year: 1998

  • Authors: Tanaka A, Sugawara A, Sawai K, Kuwahara T

  • Journal: Intern Med

3. Concealed hypothyroidism in patients with myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCA) positive renal disease

  • Year: 1999

  • Authors: Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T

  • Journal: Clinical Nephrology

4. Intraglomerular metastasis from pancreatic cancer

  • Year: 2001

  • Authors: Yokoi H, Nakata M, Sawai K, Yoshida T, Koshikawa M, Joyama S, Tanaka A, Goto M, Ueda S, Senzaki H, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

5. C4d and C4bp deposition along the glomerular capillary walls in a patient with preeclampsia

  • Year: 2001

  • Authors: Joyama S, Yoshida T, Koshikawa M, Sawai K, Yokoi H, Tanaka A, Gotoh M, Ueda S, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

6. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis

  • Year: 2003

  • Authors: Sawai K, Mori K, Mukoyama M, Sugawara A, Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K

  • Journal: Journal of the American Society of Nephrology

7. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis

  • Year: 2004

  • Authors: Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

8. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy

  • Year: 2005

  • Authors: Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K

  • Journal: FASEB Journal

9. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

  • Year: 2005

  • Authors: Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J

  • Journal: Journal of Clinical Investigation

10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

  • Year: 2005

  • Authors: Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

Kaleab Tegegne | Health Professions | Best Researcher Award

Published on by Shen Awards

Mr. Kaleab Tegegne | Health Professions | Best Researcher Award

Researcher at Debark University, Ethiopia

Kaleab Tesfaye Tegegne is a dedicated researcher and educator in the field of public health, currently serving as a Lecturer and Researcher at Debark University in Ethiopia. With a focus on epidemiology, maternal and child health, and public health research, Tegegne has significantly contributed to both academia and public health practice. He has established a solid reputation through his impactful research, leading to publications in prominent journals and securing funding for critical research initiatives. His experience spans across multiple prestigious institutions, including Hawassa College of Health Science and Debark University, where he has both taught and mentored students in public health programs. Tegegne’s academic and professional experiences are complemented by his leadership in research projects that aim to improve public health conditions in Ethiopia. His work on cerebral palsy, maternal health, and anemia showcases his ability to address pressing health challenges and make a meaningful impact on public health policies in the region.

Professional Profile

Education

Kaleab Tesfaye Tegegne’s educational background is marked by excellence and commitment to the field of public health. He holds a Master of Public Health (MPH) degree from the University of Gondar, Ethiopia, where he achieved a CGPA of 3.53. His academic journey began with a Bachelor of Science (BSc) in Public Health from Haramaya University, Ethiopia, where he earned a CGPA of 3.76. These strong academic achievements laid a solid foundation for his career in public health research and teaching. His education not only provided him with essential knowledge in epidemiology and public health but also nurtured his passion for contributing to the improvement of health systems and public health outcomes, particularly in the context of Ethiopia. Through both his education and extensive practical experience, Tegegne has developed a deep understanding of the critical health issues facing communities, which has fueled his dedication to research and public health interventions aimed at addressing these challenges.

Professional Experience

Tegegne has accumulated valuable professional experience in both academic and research settings. As a Lecturer and Researcher at Debark University since 2022, he has made significant contributions to public health education, teaching courses on epidemiology, research methodology, biostatistics, and nutrition. His role involves not only lecturing but also developing curricula and teaching materials to enhance the academic experience of students. Prior to this, Tegegne served at Hawassa College of Health Science for seven years, where he gained experience supervising undergraduate research projects, many of which were published in reputable journals. His professional journey also includes leadership in research, with several published studies focused on child health, maternal health, and epidemiology. Tegegne’s expertise extends to the successful application for competitive grants, including funding from the Global LMIC CP Register project. His professional experience has solidified his role as an influential figure in Ethiopia’s public health landscape, where his research and teaching are making a tangible difference in improving community health outcomes.

Research Interests

Tegegne’s research interests center around public health epidemiology, with a particular focus on child and maternal health. He has conducted significant research on topics such as the prevalence of anemia in women and children, the epidemiology of cerebral palsy, and the psychosocial impact of health conditions on affected families. His research is driven by a desire to understand the factors contributing to health disparities and to develop interventions that improve health outcomes, particularly in low-resource settings. Tegegne is particularly focused on issues affecting vulnerable populations, including children, pregnant women, and underserved communities in Ethiopia. His research interests also extend to broader epidemiological studies, where he aims to identify determinants of health conditions, evaluate public health programs, and inform health policies that can drive positive change in Ethiopia and similar contexts. His extensive body of work reflects his commitment to tackling some of the most pressing public health challenges facing developing countries today.

Research Skills

Tegegne possesses a diverse skill set that enhances his ability to conduct impactful public health research. He is proficient in a range of statistical and research software tools, including SPSS, STATA, Revman, Epi Info, EpiData, ArcGIS, and SaTscan. These tools are integral to his expertise in statistical modeling, data analysis, and spatial analysis, which he applies to examine public health data and identify trends and patterns. His skills in using advanced software for statistical modeling have been key in his research on epidemiology, as well as his work on health outcomes such as anemia and cerebral palsy. Additionally, Tegegne has a deep understanding of research methodology, including systematic reviews and meta-analyses, which he employs to synthesize findings from various studies. His research expertise is complemented by his ability to mentor and supervise students in research, equipping them with the skills to conduct their own research projects. Tegegne’s proficiency in both qualitative and quantitative research methods ensures that his work is rigorous, relevant, and impactful.

Awards and Honors

Throughout his academic and professional career, Kaleab Tesfaye Tegegne has received several prestigious awards and honors. Among these is a research grant from the Global LMIC CP Register project, which supports his work on cerebral palsy in Ethiopia. This award highlights the significance of his research in addressing important health challenges and improving care for affected children. Tegegne has also received competitive grants from Debark University to investigate factors related to cerebral palsy and the psychosocial impacts on parents. These awards reflect the recognition of his work by esteemed organizations and institutions. Additionally, his numerous publications in respected journals, including Scopus- and PubMed-indexed articles, have contributed to his academic reputation. His research leadership and commitment to public health have earned him recognition both in Ethiopia and internationally. These honors and awards attest to his dedication to advancing public health knowledge and improving the lives of vulnerable populations.

Conclusion

Kaleab Tesfaye Tegegne is an exemplary candidate for the Academic Research Impact Award due to his significant contributions to public health research and education. His academic achievements, including a strong educational background and numerous high-impact publications, showcase his expertise in epidemiology and public health. Tegegne’s professional experience, particularly his leadership in research and curriculum development, further strengthens his qualifications. His research interests, focusing on child and maternal health, are both timely and crucial, addressing health issues that impact vulnerable populations in Ethiopia. The awards and honors he has received reflect the recognition of his work on national and international levels. While there are opportunities for growth in expanding his research focus and building international collaborations, Tegegne’s body of work speaks to his passion for advancing public health, and his continued contributions will undoubtedly have a lasting impact on the field. His dedication to improving health outcomes in Ethiopia, particularly through his groundbreaking work on cerebral palsy, positions him as a leader in public health research.

Publication Top Notes

  • Title: Associations between prior abortion and hepatitis B virus infection among pregnant women attending health care facilities. Meta-analysis
    Authors: Kaleab Tesfaye Tegegne, Tadele Kassahun Wudu, Abebe Tadesse Tibebu, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema
    Year: 2024
    DOI: 10.1186/s40001-024-02090-1
  • Title: Spatial distribution and determinant factors of anemia among women age 15-49 years in Burkina Faso; using mixed-effects ordinal logistic regression model
    Authors: Kaleab Tesfaye Tegegne, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Tadele Kassahun Wudu, Moges Tadesse Abebe, Asmamaw Workineh Zegeye
    Year: 2024
    DOI: 10.15167/2421-4248/JPMH2024.65.2.3227
  • Title: Factors associated with clinical practice competency among nursing and health science students in Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Jemberu Chane Fetene, Tadele Kassahun Wudu, Yosef Aragaw Gonete, Abebe Tadesse Tibebu, Yideg Abinew, Moges Tadesse Abebe
    Year: 2024
    DOI: 10.15566/cjgh.v11i1.787
  • Title: Knowledge, Attitude, Practice, and Associated Factors of Implant Use in Women, Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Girma Teferi, Tadele Kassahun Wudu, Yideg Abinew, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Carlos M. Ardila
    Year: 2024
    DOI: 10.1155/2024/9978336
  • Title: Prevalence and Associated Factors of Anemia Among Pregnant Women Attending Antenatal Care at Mizan Aman General Hospital, Bench Maji Zone, Southwest, Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Seblework Abeje, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Tadele Kassahun Wudu, Mihnea-Alexandru Gaman
    Year: 2024
    DOI: 10.1155/anem/2655891
  • Title: Determinants of cerebral palsy in children: systematic review
    Authors: Kaleab Tegegne
    Year: 2023
    DOI: 10.24911/sjp.106-1670589241
  • Title: Institutional delivery knowledge, attitude, and practice among mothers of childbearing age with one or more children, Ethiopia
    Authors: Tegegne, K.T.; Wudu, T.K.; Abdisa, B.G.; Tegegne, E.T.; Tessema, M.K.
    Year: 2023
    DOI: 10.15167/2421-4248/jpmh2023.64.1.2864
  • Title: Knowledge and utilization of screening for cervical cancer among female in Ethiopia: a systemic review and meta-analysis
    Authors: T. T. Kaleab, T. T. Eleni, A. A. Abiyu, K. T. Mekibib
    Year: 2021
    DOI: 10.32113/wcrj_20211_1844
  • Title: Prevalence of Road Traffic Accidents and Associated Factors in Chuko Town, Southern Ethiopia, 2017
    Authors: Tegegne, K.T.
    Year: 2020
    DOI: 10.29252/johe.9.2.76
  • Title: Erratum: Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC (AIDS Research and Treatment (2019) 2019 (7134908) DOI: 10.1155/2019/7134908)
    Authors: Seid Ali, M.; Tesfaye Tegegne, E.; Kassa Tessema, M.; Tesfaye Tegegne, K.
    Year: 2019
    DOI: 10.1155/2019/8218107

 

Dirk Keiner | Health Professions | Innovation Excellence Award

Published on by Shen Awards

Dr. Dirk Keiner | Health Professions | Innovation Excellence Award

Pharmacist at Sophien and Hufeland Clinic Weimar, Germany

Dirk Richard Keiner is an accomplished clinical pharmacist with significant contributions to the advancement of medication safety and clinical pharmacy practice. He is the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar and holds leadership roles in several professional organizations, including the ADKA Thüringen and G³ – Arbeitsgemeinschaft für moderne Medizin e.V. Keiner has also been deeply involved in education, serving as a lecturer at various institutions such as the SRH University of Health and University of Jena. His innovative research focuses on improving drug therapy management, particularly in geriatrics, oncology, and medication safety. With a vast publication record, numerous awards, and a long-standing commitment to advancing clinical pharmacy, Keiner is a recognized leader in his field.

Professional Profile

Education:

Keiner completed his pharmaceutical studies at the Ernst-Moritz-Arndt University of Greifswald, where he graduated with a degree in Pharmacy in 1996. He conducted his diploma thesis on the analysis of valerian root essential oil. Keiner further pursued a doctorate at the Humboldt University Berlin, earning a Dr. rer. nat. with magna cum laude in 2006. His doctoral research compared various instruments used to measure the quality of life in osteoporosis patients. His strong educational foundation is complemented by various advanced professional qualifications, including specialization in Clinical Pharmacy.

Professional Experience:

Keiner’s career spans multiple leadership roles in both pharmacy practice and academia. He currently serves as the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar, a position he has held since 2017. Prior to this, he led the pharmacy at SRH Zentralklinikum Suhl and Waldkrankenhaus Eisenberg. His experience also includes extensive work in hospital and community pharmacies. Keiner has been actively involved in professional organizations, including serving as a board member of the ADKA Thüringen and as a delegate in the LAK Thüringen. His diverse professional background showcases his commitment to improving clinical pharmacy and patient care.

Research Interests:

Keiner’s research interests lie primarily in the area of medication safety, particularly in improving drug therapy management for older adults and cancer patients. He focuses on addressing gender-specific aspects of medication therapy and exploring the impact of drug-sun interactions. His work also extends to the development of tools for preventing medication errors and optimizing patient outcomes in clinical settings. Keiner’s research aims to bridge gaps in clinical pharmacy by tackling real-world challenges, such as the safe use of medications in vulnerable populations and the integration of new technologies into clinical practice.

Research Skills:

Keiner’s research skills are rooted in his extensive clinical pharmacy expertise, particularly in medication therapy management and safety. He is adept at conducting in-depth analyses of pharmaceutical interventions, particularly in geriatrics and oncology. Keiner employs various research methodologies, including qualitative and quantitative approaches, to assess the efficacy of drug therapy and the risks associated with certain medications. His ability to translate research findings into practical clinical applications is a hallmark of his work. Moreover, Keiner is skilled in evaluating and improving patient outcomes through the design and implementation of clinical studies that focus on medication errors and therapeutic optimization.

Awards and Honors:

Keiner’s exceptional contributions to clinical pharmacy have earned him numerous prestigious awards. Notable recognitions include the Sanofi-Synthelabo Prize for innovative work in clinical pharmacy, the Authors’ Prize from Krankenhauspharmazie, and the 1st place in the “Patient-Oriented Services” competition by the Dr. Hellmuth-Häussermann Foundation. In 2024, he received the ADKA Innovation Prize for his work on medication safety in the clinical setting. These accolades highlight his dedication to improving patient safety and advancing the field of clinical pharmacy. Keiner’s awards reflect his significant impact on both the scientific community and the practical application of pharmacy in healthcare settings.

Conclusion:

Dirk Richard Keiner’s career exemplifies innovation in clinical pharmacy, with a focus on improving medication safety and therapy management. His strong track record of leadership, research, and education, coupled with several prestigious awards, positions him as a deserving candidate for the Research for Innovation Excellence Award. While there are opportunities for expanding the global and interdisciplinary reach of his work, his contributions to the field of clinical pharmacy are significant, and his leadership in research and education make him a standout nominee.

Publication Top Notes

  1. AMTS Risk Profile Abiraterone | AMTS-Risk profile Abiraterone
    • Authors: Keiner, D.
    • Journal : M
    • Year: 2024
    • Volume: 47(3), pp. 106–114
  2. I’m Sorry, What? | Wie Bitte?
    • Authors: Keiner, D., Hoffmann, K.
    • Journal: Deutsche Apotheker Zeitung
    • Year: 2024
    • Volume: 2024(9)
  3. Probiotics & Co. – What Is Guaranteed? | Probiotics & Co. – What Is Guaranteed?
    • Authors : Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(12)
  4. AMTS Risk Profile Apixaban | AMTS Risk Profile Apixaban
    • Authors : Kei
    • Journal : M
    • Year: 2023
    • Volume: 46(9), pp. 319–326
  5. Check-Change-Control: Management Aspects of Arterial Hypertension in Geriatric Patients | Management Aspects of Arterial Hypertension in Geriatric Patients
    • Authors: Keiner, D., Gockel, H.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(4), pp. 114–123
  6. Risk Pyramid Allopurinol | AMTS-Risk profile Allopurinol
    • Authors: Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(1), pp. 12–19
  7. Much Helps Much – Or Is It? | Much Helps Much – Or Is It Not?
    • Authors: Keiner, D., Picksak, G.
    • Journal : Kr
    • Year: 2022
    • Volume: 43(9), pp. 375–376
  8. Gender-Specific Aspects of Cancer Management – ​​Ready for the Future? | Gender-Specific Aspects in Oncology Care – Ready for the Future?
    • Authors : Ke
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 353–362
  9. Gender-Specific Aspects of Drug Therapy – The New Clinical Challenge? | Gender-Specific Aspects of Drug Therapy: The New Clinical Challenge?
    • Authors: Keiner, D.
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 363–366
  10. Gender-Sensitive Medication Management | Gender-Sensitive Medication Management
    • Authors : None,
    • Journal : M
    • Year: 2022
    • Volume: 45(8), pp. 312–314